One dose of the HPV vaccine in girls aged 9–14 triggers strong, lasting immune responses, comparable to a full three-dose ...

China’s first domestically made nine-valent HPV vaccine, a direct competitor to Merck’s Gardasil 9, is being priced at 499 yuan ($70) per dose, the state-owned Xinhua News Agency reports. | China’s ...

The new study, funded by Gardasil’s maker, Merck, involved 4,065 sexually active young men ages 16 to 26, from 18 countries, who were HPV-free at the time of trial.The participants were followed ...

Gardasil raked in $1.55 billion in sales, down 17% from the fourth quarter of 2023. That's slightly below the $1.58 billion that analysts were expecting, according to StreetAccount estimates.

A 2025 study found that the HPV vaccine has slashed cases of cervical pre-cancer by 80 percent among women ages 20 to 24. “Kennedy’s words carry weight, making his misinformation especially ...

One of the new vaccine advisers picked by U.S. Health Secretary Robert F. Kennedy Jr. has earned thousands of dollars as an expert witness in litigation against Merck’s Gardasil vaccine, court ...

Instead of breaking records, Gardasil revenue fell 3% in 2024, with a more dramatic 17% decline in the fourth quarter, compared to 2023. In this case, ...

This has led management to withdraw guidance for $11 billion in Gardasil annual global sales by 2030. Gardasil was 13% of Merck’s sales in 2024, and roughly half of Gardasil sales tie to China.

Merck & Co.’s blockbuster vaccine Gardasil has had a roller-coaster ride in China. A post-Covid surge in demand for the cancer-preventing shot quickly deflated last year, to the point the US ...

Merck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street's expectations. The company said that sales range reflects a decision to halt shipments of Gardasil, a ...